vialroom

#retatrutide 2025-11-24

Monday15 messages3 participantstimes are UTC
Highlights from this day
  • amsterdam_aliquot — Janoshik came back 98.6 on one lot and 99.4 on the next from the same Homopeptide, both fine 21:12
  • amsterdam_aliquot — sat at 1 for 7 months rather than climbing and it kept working, so i never went up energy expenditure isnt something i could feel, though my sleep tracker disagreed… 21:17
  • first_month_fi — genuine question triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, ill dig out the number 22:14

is TRIUMPH the phase 3 programme

AA

Janoshik came back 98.6 on one lot and 99.4 on the next from the same Homopeptide, both fine

low and slow

AA

sat at 1 for 7 months rather than climbing and it kept working, so i never went up
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

FM

genuine question triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, ill dig out the number

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
FM

no idea whether the heart rate settles for everyone, mine did and one log isnt data

*VendorInvestigate not the other one